首页 > 最新文献

Medicina Clinica最新文献

英文 中文
Leiomioma perianal: una entidad poco frecuente 会阴肌瘤:一种不常见的临床实体。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 DOI: 10.1016/j.medcli.2024.04.034
Raquel Ruiz-Fernández , Daniel Fernández-Martínez , Iván Fernández-Vega
{"title":"Leiomioma perianal: una entidad poco frecuente","authors":"Raquel Ruiz-Fernández , Daniel Fernández-Martínez , Iván Fernández-Vega","doi":"10.1016/j.medcli.2024.04.034","DOIUrl":"10.1016/j.medcli.2024.04.034","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"163 9","pages":"Pages 477-478"},"PeriodicalIF":2.6,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141727425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain 确定西班牙戈谢病患者报告结果指标 (PROM) 和患者报告体验指标 (PREM)。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 DOI: 10.1016/j.medcli.2024.06.006
Pilar Giraldo , María Camprodón , Paloma Cerro Alcolea , Elena Gras-Colomer , Daiana Ibarretxe , Sunil Lakhwani , Elvira Mora , María Purificación Velasco Calderón , Montserrat Morales-Conejo

Background

Patient-reported outcome measures (PROMs) and patient-reported experiences measures (PREMs) are crucial for understanding the impact of GD on quality of life and patient's perceptions on care, but also to guide decision-making processes. Nevertheless, no specific PREMs in GD have been published, neither PROMs for Spanish GD patients have been developed.

Methods

Two project coordinators selected key-points to be included in a PROMs/PREMs questionnaire, and the scientific committee and a group of expert patients contributed to the initial draft. Then, 9 meetings with experts were held to discuss controversial points. After, a questionnaire with 103 items regarding symptomatology, aspects of daily life and care experience was developed. Finally, it was conducted a Delphi survey among a multidisciplinary group of experts in GD.

Results

Consensus was reached on 85 out of the 103 items. Recommendations on PROMs and PREMs regarding symptomatology, aspects of daily life and care experience were obtained. Consensus was reached on the importance of considering fatigue, concentration problems, and communication issues in GD patients using 5-step analog scales. Panelists recommended asking GD patients about the impact on social functioning and work/school performance. Finally, consensus was reached on considering care experiences, such as treatment satisfaction, treatment interruptions or transitions and healthcare professionals involved in patient's management to perceive patient's perceptions.

Conclusion

This expert consensus may help developing GD-specific PROMs/PREMs for improving GD management. Properly developed and validated PROMs/PREMs may help decision-making, establishing patient-tailored therapeutic and follow-up goals.
背景:患者报告的结果测量(PROMs)和患者报告的体验测量(PREMs)对于了解 GD 对生活质量的影响和患者对护理的看法至关重要,同时也能指导决策过程。然而,目前还没有专门针对 GD 的 PREMs 出版,也没有针对西班牙 GD 患者的 PROMs:方法:两名项目协调人选择了要纳入 PROMs/PREMs 问卷的关键点,科学委员会和一组患者专家对初稿做出了贡献。然后,与专家举行了 9 次会议,讨论有争议的问题。之后,制定了一份包含 103 个项目的调查问卷,内容涉及症状、日常生活方面和护理经验。最后,在一个多学科的广东专家小组中进行了德尔菲调查:结果:在 103 个项目中,有 85 个项目达成了共识。就症状学、日常生活和护理体验方面的 PROM 和 PREM 提出了建议。就使用五级模拟量表考虑广东话患者疲劳、注意力不集中和沟通问题的重要性达成了共识。专家组成员建议向广东籍患者询问其对社会功能和工作/学业表现的影响。最后,专家们就考虑护理经验达成共识,如治疗满意度、治疗中断或过渡以及参与患者管理的医护人员对患者感受的看法:结论:这一专家共识有助于开发针对广东的 PROMs/PREMs,以改善广东的管理。经适当开发和验证的 PROMs/PREMs 有助于决策、制定适合患者的治疗和随访目标。
{"title":"Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain","authors":"Pilar Giraldo ,&nbsp;María Camprodón ,&nbsp;Paloma Cerro Alcolea ,&nbsp;Elena Gras-Colomer ,&nbsp;Daiana Ibarretxe ,&nbsp;Sunil Lakhwani ,&nbsp;Elvira Mora ,&nbsp;María Purificación Velasco Calderón ,&nbsp;Montserrat Morales-Conejo","doi":"10.1016/j.medcli.2024.06.006","DOIUrl":"10.1016/j.medcli.2024.06.006","url":null,"abstract":"<div><h3>Background</h3><div>Patient-reported outcome measures (PROMs) and patient-reported experiences measures (PREMs) are crucial for understanding the impact of GD on quality of life and patient's perceptions on care, but also to guide decision-making processes. Nevertheless, no specific PREMs in GD have been published, neither PROMs for Spanish GD patients have been developed.</div></div><div><h3>Methods</h3><div>Two project coordinators selected key-points to be included in a PROMs/PREMs questionnaire, and the scientific committee and a group of expert patients contributed to the initial draft. Then, 9 meetings with experts were held to discuss controversial points. After, a questionnaire with 103 items regarding symptomatology, aspects of daily life and care experience was developed. Finally, it was conducted a Delphi survey among a multidisciplinary group of experts in GD.</div></div><div><h3>Results</h3><div>Consensus was reached on 85 out of the 103 items. Recommendations on PROMs and PREMs regarding symptomatology, aspects of daily life and care experience were obtained. Consensus was reached on the importance of considering fatigue, concentration problems, and communication issues in GD patients using 5-step analog scales. Panelists recommended asking GD patients about the impact on social functioning and work/school performance. Finally, consensus was reached on considering care experiences, such as treatment satisfaction, treatment interruptions or transitions and healthcare professionals involved in patient's management to perceive patient's perceptions.</div></div><div><h3>Conclusion</h3><div>This expert consensus may help developing GD-specific PROMs/PREMs for improving GD management. Properly developed and validated PROMs/PREMs may help decision-making, establishing patient-tailored therapeutic and follow-up goals.</div></div>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":"163 9","pages":"Pages 449-457"},"PeriodicalIF":2.6,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rasmussen aneurysm in a patient with chronic inhaled drug use. 一名长期吸入药物患者的拉斯穆森动脉瘤。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-14 DOI: 10.1016/j.medcli.2024.08.017
Diana Alegre-González, Marlon Vasquez-Burbano, Alba Gil-Arcija
{"title":"Rasmussen aneurysm in a patient with chronic inhaled drug use.","authors":"Diana Alegre-González, Marlon Vasquez-Burbano, Alba Gil-Arcija","doi":"10.1016/j.medcli.2024.08.017","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.017","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atherosclerosis, vascular calcification and osteoporosis. 动脉粥样硬化、血管钙化和骨质疏松症。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-14 DOI: 10.1016/j.medcli.2024.07.004
Carmen Valero, Jesús González Macías

Numerous epidemiological studies link bone loss with vascular calcification and cardiovascular disease. Osteoporosis and atherosclerosis share risk factors and are likely to share pathogenic mechanisms as well. On the other hand, drugs used in the treatment of osteoporosis could influence cardiovascular risk, just as those used in cardiovascular disease could affect bone mineral density and the development of fractures.

大量流行病学研究将骨质流失与血管钙化和心血管疾病联系在一起。骨质疏松症和动脉粥样硬化具有相同的风险因素,也可能具有相同的致病机制。另一方面,治疗骨质疏松症的药物可能会影响心血管风险,正如治疗心血管疾病的药物可能会影响骨矿密度和骨折的发生一样。
{"title":"Atherosclerosis, vascular calcification and osteoporosis.","authors":"Carmen Valero, Jesús González Macías","doi":"10.1016/j.medcli.2024.07.004","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.07.004","url":null,"abstract":"<p><p>Numerous epidemiological studies link bone loss with vascular calcification and cardiovascular disease. Osteoporosis and atherosclerosis share risk factors and are likely to share pathogenic mechanisms as well. On the other hand, drugs used in the treatment of osteoporosis could influence cardiovascular risk, just as those used in cardiovascular disease could affect bone mineral density and the development of fractures.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study. 住院中心静脉导管携带者和非携带者的上肢深静脉血栓形成:一项回顾性队列研究。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-11 DOI: 10.1016/j.medcli.2024.09.008
José Ángel Novalbos-Partida, José Antonio Rueda-Camino, María Angelina-García, M Dolores Joya-Seijo, Davinia Trujillo-Luque, Raquel Barba-Martín

Objectives: Prognostic differences between central venous catheters (CVC) carriers and non-carriers, who have upper extremity deep vein thrombosis (UEDVT), have been described; however, evidence in hospitalized patients is limited.

Materials and methods: This retrospective cohort study included hospitalized patients from March 2012 to March 2023 with UEDVT, classified into CVC-associated and non-CVC-associated UEDVT groups. Rates of thrombotic recurrence, hemorrhage, post-thrombotic syndrome, and death from pulmonary embolism were analyzed using Kaplan-Meier curves and Cox proportional hazards models.

Results: A total of 135 patients were included (76 with CVC and 59 without CVC), with a mean age of 67±15 years and 44% female. No significant differences were observed in the incidence of the combined endpoint between CVC non-carriers and carriers (5.45 vs 6.74 per 1000 patient-months respectively; HR: 1.26; 95% CI: 0.51-3.06). After multivariable adjustment, no significant differences in risk were detected (HR: 1.09; 95% CI: 0.44-2.72).

Conclusions: There are no significant prognostic differences between patients with and without CVC hospitalized for UEDVT.

目的:中心静脉导管(CVC)携带者和非携带者在上肢深静脉血栓形成(UEDVT)的预后方面存在差异,但住院患者的证据有限:这项回顾性队列研究纳入了 2012 年 3 月至 2023 年 3 月期间患有 UEDVT 的住院患者,分为 CVC 相关 UEDVT 组和非 CVC 相关 UEDVT 组。研究采用 Kaplan-Meier 曲线和 Cox 比例危险模型分析了血栓复发率、出血率、血栓后综合征和肺栓塞致死率:共纳入135例患者(76例使用CVC,59例未使用CVC),平均年龄(67±15)岁,女性占44%。非 CVC 携带者和携带者的合并终点发病率无明显差异(分别为每 1000 患者月 5.45 例和 6.74 例;HR:1.26;95% CI:0.51-3.06)。经多变量调整后,未发现明显的风险差异(HR:1.09;95% CI:0.44-2.72):结论:因 UEDVT 住院的患者中,有 CVC 和没有 CVC 的患者在预后方面没有明显差异。
{"title":"Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study.","authors":"José Ángel Novalbos-Partida, José Antonio Rueda-Camino, María Angelina-García, M Dolores Joya-Seijo, Davinia Trujillo-Luque, Raquel Barba-Martín","doi":"10.1016/j.medcli.2024.09.008","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.09.008","url":null,"abstract":"<p><strong>Objectives: </strong>Prognostic differences between central venous catheters (CVC) carriers and non-carriers, who have upper extremity deep vein thrombosis (UEDVT), have been described; however, evidence in hospitalized patients is limited.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included hospitalized patients from March 2012 to March 2023 with UEDVT, classified into CVC-associated and non-CVC-associated UEDVT groups. Rates of thrombotic recurrence, hemorrhage, post-thrombotic syndrome, and death from pulmonary embolism were analyzed using Kaplan-Meier curves and Cox proportional hazards models.</p><p><strong>Results: </strong>A total of 135 patients were included (76 with CVC and 59 without CVC), with a mean age of 67±15 years and 44% female. No significant differences were observed in the incidence of the combined endpoint between CVC non-carriers and carriers (5.45 vs 6.74 per 1000 patient-months respectively; HR: 1.26; 95% CI: 0.51-3.06). After multivariable adjustment, no significant differences in risk were detected (HR: 1.09; 95% CI: 0.44-2.72).</p><p><strong>Conclusions: </strong>There are no significant prognostic differences between patients with and without CVC hospitalized for UEDVT.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between hypogonadism and severity of chronic obstructive pulmonary disease: A cross-sectional study. 性腺功能减退症与慢性阻塞性肺病严重程度之间的关系:一项横断面研究。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-09 DOI: 10.1016/j.medcli.2024.08.016
Horacio Matias Castro, Joaquin Maritano Furcada, Eduardo Luis De Vito, Sebastian Matias Suarez, Pablo Knoblovits, Pablo Rene Costanzo

Introduction and objectives: Chronic obstructive pulmonary disease (COPD) frequently coexists with other comorbidities, including hypogonadism. However, the association between COPD severity and hypogonadism remains controversial. This study aimed to evaluate this association and compare the clinical characteristics of hypogonadal and eugonadal COPD patients.

Materials and methods: A cross-sectional study including men with stable COPD was performed. Hypogonadism was diagnosed based on the presence of symptoms, according to the Androgen Deficiency in Aging Males questionnaire, and a total testosterone deficit (<300ng/dL). COPD severity was classified according to the Spanish COPD guideline risk classification. A multivariate logistic regression analysis was performed in order to evaluate the relationship between COPD severity and hypogonadism.

Results: 134 subjects were recruited. The prevalence of hypogonadism was higher in severe COPD than in mild COPD, with a prevalence ratio of 1.8 (p=0.007). An increased odds of hypogonadism was observed in severe COPD subjects (OR 2.60, 95% CI 1.23-5.48, p=0.012) independent of age, body mass index, cardiovascular disease, and chronic renal failure. Hypogonadal COPD patients exhibited lower percentage levels of FVC and FEV1 and a higher degree of dyspnea than compared to eugonadal COPD patients.

Conclusion: Patients with severe COPD had a higher prevalence of hypogonadism compared to those with mild COPD. Additionally, severe COPD was identified as an independent risk factor for hypogonadism. These findings suggest that hypogonadism should be evaluated in patients with COPD, particularly in those with severe disease.

引言和目的:慢性阻塞性肺疾病(COPD)经常与其他合并症并存,包括性腺功能减退症。然而,慢性阻塞性肺病的严重程度与性腺功能减退之间的关联仍存在争议。本研究旨在评估这种关联,并比较性腺功能低下和性腺功能正常的慢性阻塞性肺病患者的临床特征:材料和方法:本研究对患有稳定型慢性阻塞性肺病的男性患者进行了横断面研究。根据 "老年男性雄激素缺乏症 "问卷调查和总睾酮不足(结果:134 名受试者被纳入研究:共招募了 134 名受试者。重度慢性阻塞性肺病患者的性腺功能减退症患病率高于轻度慢性阻塞性肺病患者,患病率比为 1.8(P=0.007)。重度慢性阻塞性肺病患者出现性腺功能减退症的几率增加(OR 2.60,95% CI 1.23-5.48,p=0.012),与年龄、体重指数、心血管疾病和慢性肾功能衰竭无关。与优生优育的慢性阻塞性肺病患者相比,性腺功能低下的慢性阻塞性肺病患者的FVC和FEV1百分比水平较低,呼吸困难程度较高:结论:与轻度慢性阻塞性肺病患者相比,重度慢性阻塞性肺病患者的性腺功能低下发生率更高。结论:与轻度慢性阻塞性肺病患者相比,重度慢性阻塞性肺病患者的性腺功能减退症发病率更高。这些研究结果表明,应评估慢性阻塞性肺病患者的性腺功能减退症,尤其是重症患者。
{"title":"Association between hypogonadism and severity of chronic obstructive pulmonary disease: A cross-sectional study.","authors":"Horacio Matias Castro, Joaquin Maritano Furcada, Eduardo Luis De Vito, Sebastian Matias Suarez, Pablo Knoblovits, Pablo Rene Costanzo","doi":"10.1016/j.medcli.2024.08.016","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.016","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Chronic obstructive pulmonary disease (COPD) frequently coexists with other comorbidities, including hypogonadism. However, the association between COPD severity and hypogonadism remains controversial. This study aimed to evaluate this association and compare the clinical characteristics of hypogonadal and eugonadal COPD patients.</p><p><strong>Materials and methods: </strong>A cross-sectional study including men with stable COPD was performed. Hypogonadism was diagnosed based on the presence of symptoms, according to the Androgen Deficiency in Aging Males questionnaire, and a total testosterone deficit (<300ng/dL). COPD severity was classified according to the Spanish COPD guideline risk classification. A multivariate logistic regression analysis was performed in order to evaluate the relationship between COPD severity and hypogonadism.</p><p><strong>Results: </strong>134 subjects were recruited. The prevalence of hypogonadism was higher in severe COPD than in mild COPD, with a prevalence ratio of 1.8 (p=0.007). An increased odds of hypogonadism was observed in severe COPD subjects (OR 2.60, 95% CI 1.23-5.48, p=0.012) independent of age, body mass index, cardiovascular disease, and chronic renal failure. Hypogonadal COPD patients exhibited lower percentage levels of FVC and FEV<sub>1</sub> and a higher degree of dyspnea than compared to eugonadal COPD patients.</p><p><strong>Conclusion: </strong>Patients with severe COPD had a higher prevalence of hypogonadism compared to those with mild COPD. Additionally, severe COPD was identified as an independent risk factor for hypogonadism. These findings suggest that hypogonadism should be evaluated in patients with COPD, particularly in those with severe disease.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumoral osteomalacia due to hemangiopericytoma. 因血细胞瘤引起的肿瘤性骨软化症。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-09 DOI: 10.1016/j.medcli.2024.08.015
Julia Costas Eimil, Antonia Rego Iraeta, Lucía García Bernardo
{"title":"Tumoral osteomalacia due to hemangiopericytoma.","authors":"Julia Costas Eimil, Antonia Rego Iraeta, Lucía García Bernardo","doi":"10.1016/j.medcli.2024.08.015","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.015","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peritonitis due to Kocuria rhizophila in a patient treated with peritoneal dialysis. 一名接受腹膜透析治疗的患者因根瘤梭菌引发腹膜炎。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.1016/j.medcli.2024.08.013
Carolina Fonseca de Jesus Silva, Karen Rivero Garcia, Pilar Fraile Gómez
{"title":"Peritonitis due to Kocuria rhizophila in a patient treated with peritoneal dialysis.","authors":"Carolina Fonseca de Jesus Silva, Karen Rivero Garcia, Pilar Fraile Gómez","doi":"10.1016/j.medcli.2024.08.013","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.08.013","url":null,"abstract":"","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatoses in patients with inflammatory bowel disease under tumor necrosis factor-alpha inhibitors treatment. 接受肿瘤坏死因子-α抑制剂治疗的炎症性肠病患者的皮肤病。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-07 DOI: 10.1016/j.medcli.2024.09.004
Carolina Mundim Couto Magalhães, Marina Ribeiro Bartholo, Bernardo Henrique Mendes Correa, Maria de Lourdes Abreu Ferrari, Teresa Cristina Abreu Ferrari

Introduction: Tumor necrosis factor-alpha inhibitor (anti-TNF-α) agents are essential in treating inflammatory bowel diseases (IBD). Their use, however, may cause dermatoses. This study aims to characterize the dermatoses in IBD patients on anti-TNF-α therapy.

Methods: A total of 175 IBD patients, 105 (60%) on anti-TNF-α therapy were consecutively selected in a Brazilian referral center of gastroenterology and were evaluated by a dermatologist, regardless of whether they had dermatological complaints.

Results: The most prevalent disorders in patients receiving anti-TNF-α were skin infections (52.4%), unspecified alopecia not associated with psoriasiform eruptions (32.4%), seborrheic dermatitis (27.6%), infusion/injection reactions (14.5%), and psoriasiform eruptions (11.4%). The group not on anti-TNF-α treatment also presented a high prevalence of infection, seborrheic dermatitis, and alopecia, but no psoriasiform eruptions. There was a higher prevalence of dermatoses, when considered together, in patients taking anti-TNF-α. The use of these agents was independently associated with presence of dermatoses when grouped.

Conclusion: The prevalence of dermatoses, considering together, was higher in the anti-TNF-α group. Infections, alopecia, seborrheic dermatitis, administration reactions, and psoriasiform eruptions were the most frequent dermatoses in patients taking anti-TNF-α.

导言:抗肿瘤坏死因子-α抑制剂(anti-TNF-α)是治疗炎症性肠病(IBD)的重要药物。然而,使用这些药物可能会引起皮肤病。本研究旨在分析接受抗肿瘤坏死因子-α治疗的IBD患者的皮肤病特征:方法:在巴西一家胃肠病学转诊中心连续选取了175名IBD患者,其中105人(60%)正在接受抗TNF-α治疗,无论他们是否有皮肤病主诉,均由皮肤科医生进行了评估:接受抗肿瘤坏死因子-α治疗的患者中最常见的疾病是皮肤感染(52.4%)、与银屑病样皮疹无关的不明原因脱发(32.4%)、脂溢性皮炎(27.6%)、输液/注射反应(14.5%)和银屑病样皮疹(11.4%)。未接受抗肿瘤坏死因子-α治疗的患者中,感染、脂溢性皮炎和脱发的发病率也很高,但没有银屑病样疹子。综合考虑,服用抗肿瘤坏死因子-α的患者皮肤病发病率较高。结论:将抗肿瘤坏死因子-α与皮肤病的发生率结合起来看,使用这些药物与皮肤病的发生率是独立相关的:结论:综合考虑,抗肿瘤坏死因子-α组的皮肤病发病率较高。感染、脱发、脂溢性皮炎、用药反应和牛皮癣是服用抗肿瘤坏死因子-α的患者最常见的皮肤病。
{"title":"Dermatoses in patients with inflammatory bowel disease under tumor necrosis factor-alpha inhibitors treatment.","authors":"Carolina Mundim Couto Magalhães, Marina Ribeiro Bartholo, Bernardo Henrique Mendes Correa, Maria de Lourdes Abreu Ferrari, Teresa Cristina Abreu Ferrari","doi":"10.1016/j.medcli.2024.09.004","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.09.004","url":null,"abstract":"<p><strong>Introduction: </strong>Tumor necrosis factor-alpha inhibitor (anti-TNF-α) agents are essential in treating inflammatory bowel diseases (IBD). Their use, however, may cause dermatoses. This study aims to characterize the dermatoses in IBD patients on anti-TNF-α therapy.</p><p><strong>Methods: </strong>A total of 175 IBD patients, 105 (60%) on anti-TNF-α therapy were consecutively selected in a Brazilian referral center of gastroenterology and were evaluated by a dermatologist, regardless of whether they had dermatological complaints.</p><p><strong>Results: </strong>The most prevalent disorders in patients receiving anti-TNF-α were skin infections (52.4%), unspecified alopecia not associated with psoriasiform eruptions (32.4%), seborrheic dermatitis (27.6%), infusion/injection reactions (14.5%), and psoriasiform eruptions (11.4%). The group not on anti-TNF-α treatment also presented a high prevalence of infection, seborrheic dermatitis, and alopecia, but no psoriasiform eruptions. There was a higher prevalence of dermatoses, when considered together, in patients taking anti-TNF-α. The use of these agents was independently associated with presence of dermatoses when grouped.</p><p><strong>Conclusion: </strong>The prevalence of dermatoses, considering together, was higher in the anti-TNF-α group. Infections, alopecia, seborrheic dermatitis, administration reactions, and psoriasiform eruptions were the most frequent dermatoses in patients taking anti-TNF-α.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriateness of urinary catheterization in the hospital setting: A multicenter observational study. 医院环境中导尿的适当性:一项多中心观察研究。
IF 2.6 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-07 DOI: 10.1016/j.medcli.2024.09.003
Ignasi Garcia-Olivé, Agustín Urrutia, Eva Janeiro, Marta Gutiérrez-Valencia, Leire Leache Alegría, Jose Ignacio Pijoan Zubizarreta, Elisabeth Carreras Robert, Rosa García Diez

Objective: The objective of this study is to analyze the appropriateness of the indication for urinary catheterization (UC) in hospitalized patients and to analyze possible associated factors.

Methods: Cross-sectional observational study conducted in 15 hospitals. Patients over the age of 18 with UC were included in the study. Information on age, sex, healthcare area, documentation of the order in the medical record, and reason for UC was collected. Indications were considered appropriate according to the Centers for Disease Control's (CDC) Urinary Tract Infection Prevention Guidelines. Logistic regression was used to study the relationship of different variables with the appropriateness of UC and the presence of documentation of the reason for UC.

Results: 696 patients with UC at the time of evaluation were included, with a mean age of 73.3 years (SD 14.6), and 45.0% of them were female. The main indications for UC were preoperative, hemodynamic instability, and acute urinary retention. In 17.4% of cases, the reason for UC was not documented, and the prevalence of inappropriateness was 20.3%. Inappropriateness of UC was higher in the Emergency Department (35.1%), followed by medical services (17.2%) and surgical services (8.4%) (p<0.001 in all comparisons). Appropriateness was lower in older patients (p=0.021) and in centers with a higher number of beds (p<0.001).

Conclusions: Unappropriateness of urinary catheterization is a significant problem in our centers, especially in the Emergency Department and in older patients. Specific and multifocal quality improvement programs are needed to enhance knowledge of appropriate indications for UC and potential adverse consequences.

研究目的本研究旨在分析住院患者导尿(UC)指征的适当性,并分析可能的相关因素:方法:在 15 家医院开展横断面观察研究。方法:在 15 家医院进行横断面观察研究,研究对象包括 18 岁以上的 UC 患者。研究收集了患者的年龄、性别、医疗区域、病历中的医嘱记录以及 UC 的原因等信息。根据美国疾病控制中心(CDC)的《尿路感染预防指南》,尿路感染的指征被认为是适当的。采用逻辑回归法研究不同变量与尿路感染是否适当以及是否有尿路感染原因记录的关系:共纳入了 696 名在评估时患有尿路感染的患者,平均年龄为 73.3 岁(SD 14.6),其中 45.0% 为女性。UC 的主要适应症是术前、血流动力学不稳定和急性尿潴留。17.4%的病例未记录尿潴留的原因,不适当尿潴留的发生率为20.3%。急诊科(35.1%)、内科(17.2%)和外科(8.4%)的尿潴留发生率较高(P结论:在我们的医疗中心,导尿不当是一个严重问题,尤其是在急诊科和老年患者中。需要开展具体的、多方面的质量改进计划,以提高人们对尿路导管术的适当适应症和潜在不良后果的认识。
{"title":"Appropriateness of urinary catheterization in the hospital setting: A multicenter observational study.","authors":"Ignasi Garcia-Olivé, Agustín Urrutia, Eva Janeiro, Marta Gutiérrez-Valencia, Leire Leache Alegría, Jose Ignacio Pijoan Zubizarreta, Elisabeth Carreras Robert, Rosa García Diez","doi":"10.1016/j.medcli.2024.09.003","DOIUrl":"https://doi.org/10.1016/j.medcli.2024.09.003","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to analyze the appropriateness of the indication for urinary catheterization (UC) in hospitalized patients and to analyze possible associated factors.</p><p><strong>Methods: </strong>Cross-sectional observational study conducted in 15 hospitals. Patients over the age of 18 with UC were included in the study. Information on age, sex, healthcare area, documentation of the order in the medical record, and reason for UC was collected. Indications were considered appropriate according to the Centers for Disease Control's (CDC) Urinary Tract Infection Prevention Guidelines. Logistic regression was used to study the relationship of different variables with the appropriateness of UC and the presence of documentation of the reason for UC.</p><p><strong>Results: </strong>696 patients with UC at the time of evaluation were included, with a mean age of 73.3 years (SD 14.6), and 45.0% of them were female. The main indications for UC were preoperative, hemodynamic instability, and acute urinary retention. In 17.4% of cases, the reason for UC was not documented, and the prevalence of inappropriateness was 20.3%. Inappropriateness of UC was higher in the Emergency Department (35.1%), followed by medical services (17.2%) and surgical services (8.4%) (p<0.001 in all comparisons). Appropriateness was lower in older patients (p=0.021) and in centers with a higher number of beds (p<0.001).</p><p><strong>Conclusions: </strong>Unappropriateness of urinary catheterization is a significant problem in our centers, especially in the Emergency Department and in older patients. Specific and multifocal quality improvement programs are needed to enhance knowledge of appropriate indications for UC and potential adverse consequences.</p>","PeriodicalId":18578,"journal":{"name":"Medicina Clinica","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142623744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medicina Clinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1